Search research articles
Contact Us
Filters
Showing results (561-570 of 571) with videos related to
Page
of 58
Sort By:
Cancer Discovery
|
November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Jiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
Or-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Cell
|
November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Cell
|
December 15, 2021
Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps
Bob Chen, Cherie' R Scurrah, Eliot T McKinley, et al.
Cell Reports. Medicine
|
June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants
Or-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 3, 2025
A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunity
Kamil Slowikowski, Pritha Sen, Christopher V Cosgriff, et al.
Digital Discovery
|
August 9, 2024
Developments and applications of the OPTIMADE API for materials discovery, design, and data exchange
Matthew L Evans, Johan Bergsma, Andrius Merkys, et al.
Nature
|
January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or-Yam Revach, Seth Anderson, et al.
Cell
|
April 23, 2024
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
Mariko Takahashi, Harrison B Chong, Siwen Zhang, et al.
Cell
|
August 27, 2021
Spatially organized multicellular immune hubs in human colorectal cancer
Karin Pelka, Matan Hofree, Jonathan H Chen, et al.
Page
of 58
Search research articles
Search
Showing results (561-570 of 571) with videos related to
Sort By:
Page
of 58
Cancer Discovery
|
November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Jiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
Or-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Cell
|
November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Cell
|
December 15, 2021
Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps
Bob Chen, Cherie' R Scurrah, Eliot T McKinley, et al.
Cell Reports. Medicine
|
June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants
Or-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 3, 2025
A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunity
Kamil Slowikowski, Pritha Sen, Christopher V Cosgriff, et al.
Digital Discovery
|
August 9, 2024
Developments and applications of the OPTIMADE API for materials discovery, design, and data exchange
Matthew L Evans, Johan Bergsma, Andrius Merkys, et al.
Nature
|
January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or-Yam Revach, Seth Anderson, et al.
Cell
|
April 23, 2024
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
Mariko Takahashi, Harrison B Chong, Siwen Zhang, et al.
Cell
|
August 27, 2021
Spatially organized multicellular immune hubs in human colorectal cancer
Karin Pelka, Matan Hofree, Jonathan H Chen, et al.
Page
of 58